Review article: The management of acute liver failure

J. N. Plevris*, M. Schina, P. C. Hayes

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Acute liver failure (ALF) is a relatively uncommon but dramatic clinical syndrome with high mortality rates, in which a previously normal liver fails within days or weeks. Paracetamol overdose remains the major cause of ALF in the UK, while vital hepatitis is the commonest cause world-wide, Cerebral oedema is the leading cause of death in patients with ALF. Despite advances in intensive care and the development of new treatment modalities, ALF remains a condition of high mortality best managed in specialist centres. Orthotopic liver transplantation is the only new treatment modality that has made a significant impact in improving outcome. Bioartificial liver support systems and hepatocyte transplantation are new promising treatment options that may change the management of ALF in the future.

Original languageEnglish
Pages (from-to)405-418
Number of pages14
JournalAlimentary Pharmacology and Therapeutics
Volume12
Issue number5
DOIs
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Dive into the research topics of 'Review article: The management of acute liver failure'. Together they form a unique fingerprint.

Cite this